GURUFOCUS.COM » STOCK LIST » Financial Services » Capital Markets » Cowen Inc (NAS:COWN) » Definitions » Research & Development

Cowen (COWN) Research & Development : $0 Mil (TTM As of Dec. 2022)


View and export this data going back to 2006. Start your Free Trial

What is Cowen Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Cowen's Research & Development for the three months ended in Dec. 2022 was $0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2022 was $0 Mil.


Cowen Research & Development Historical Data

The historical data trend for Cowen's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cowen Research & Development Chart

Cowen Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Cowen Quarterly Data
Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Cowen Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cowen  (NAS:COWN) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Cowen Research & Development Related Terms

Thank you for viewing the detailed overview of Cowen's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Cowen (COWN) Business Description

Traded in Other Exchanges
N/A
Address
599 Lexington Avenue, 20th Floor, New York, NY, USA, 10022
Cowen provides financial services in two segments: the operating company, which includes Cowen Investment Management, investment banking, the markets division, and the research division; and the asset company, which consists of private investments, real estate investments and other legacy investment strategies. Cowen offers investment management services to institutional investors worldwide. The company offers its investment banking and research services to corporations and institutional investors in the U.S. and Europe. Revenue comes primarily through investment banking and brokerage services.
Executives
Lorence H. Kim director C/O SERES HEALTH, INC., 161 FIRST STREET, CAMBRIDGE MA 02472
Brett H Barth director COWEN INC., 599 LEXINGTON AVENUE, NEW YORK NY 10022
Stephen Lasota officer: Chief Financial Officer 599 LEXINGTON AVENUE, NEW YORK NY 10022
John J Holmes officer: Chief Administrative Officer COWEN GROUP, INC., 599 LEXINGTON AVENUE, NEW YORK NY 10022
Owen S Littman officer: General Counsel COWEN GROUP, INC., 599 LEXINGTON AVENUE, NEW YORK NY 10022
Jeffrey M Solomon 10 percent owner, officer: Chmn Inv Comm/Prod Dev 599 LEXINGTON AVENUE 20TH FLOOR, NEW YORK NY 10022
Gregg A Gonsalves director C/O CEDAR REALTY TRUST, INC., 44 SOUTH BAYLES AVENUE, PORT WASHINGTON NY 11050
Lawrence E Leibowitz director C/O NYSE EURONEXT, 11 WALL STREET, NEW YORK NY 10005
Margaret L Poster director C/O COWEN INC., 599 LEXINGTON AVENUE, NEW YORK NY 10022
Peter A Cohen director, 10 percent owner, officer: Chairman, CEO, President 40 WEST 57TH STREET, SUITE 2020, NEW YORK NY 10019
Douglas Rediker director 599 LEXINGON AVENUE, NEW YORK NY 11022
Michael Singer officer: CEO & President, Ramius LLC 599 LEXINGTON AVENUE, NEW YORK NY 10022
Jerome S Markowitz director C/O COUGAR TRADING, 375 PARK AVENUE, NEW YORK NY 10021
Labranche George M L Iv director, officer: Senior Managing Director ONE EXCHANGE PLAZA, NEW YORK NY 10006-3008
Labranche & Co Inc other: See Footnotes (1) and (2) ONE EXCHANGE PLAZA, NEW YORK NY 10006-3008